Drugs Made In America Acquisition Corp. - Ordinary Shares

Share · KYG2847J1040 · DMAA (XNAS)

No Price

06.03.2026 21:00

Current Prices from Drugs Made In America Acquisition Corp. - Ordinary Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	DMAA	USD	06.03.2026 21:00	10,47 USD	-0,02 USD -0,19 %
IEX	DMAA	USD	06.03.2026 16:19	10,46 USD	-0,03 USD -0,29 %

Share Float & Liquidity

Free Float 86,31 %

Shares Float 28,93 M

Shares Outstanding 33,52 M

Company Profile for Drugs Made In America Acquisition Corp. - Ordinary Shares Share

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

AI Analysis of Drugs Made In America Acquisition Corp. - Ordinary Shares

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Drugs Made In America Acquisition Corp. - Ordinary Shares

No AI threads available for this company yet.

Company Data

Name Drugs Made In America Acquisition Corp. - Ordinary Shares

Company Drugs Made In America Acquisition Corp. Ordinary Shares

Symbol DMAA

Website https://dmaacorp.com

Primary Exchange

NASDAQ

ISIN KYG2847J1040

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Lynn Stockwell

Market Capitalization 351 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 1 East Broward Blvd Suite 700, 33301 Fort Lauderdale

IPO Date 2025-01-27

Ticker Symbols

Name	Symbol
NASDAQ	DMAA

More Shares

Investors who hold Drugs Made In America Acquisition Corp. - Ordinary Shares also have the following shares in their portfolio:

LBBW STUFENZINS 18/25 Bond

NEBLIO Crypto

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog